SK Bioscience Co Ltd (302440) — Strategic Asset Allocation Index
SK Bioscience Co Ltd (302440) has a Strategic Asset Allocation Index of 16.7% as of September 2022. Strategic assets (PP&E of ₩285.90 Billion plus long-term investments of ₩-) total ₩285.90 Billion, measured against net assets of ₩1.71 Trillion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
SK Bioscience Co Ltd Strategic Asset Allocation Index (2020–2021)
This chart shows how SK Bioscience Co Ltd's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of September 2022, the index stands at 16.7%, representing strategic assets of ₩285.90 Billion against net assets of ₩1.71 Trillion KRW. Explore how efficiently does SK Bioscience Co Ltd generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for SK Bioscience Co Ltd (2020–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for SK Bioscience Co Ltd from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of SK Bioscience Co Ltd.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 13.8% | ₩220.98 Billion | ₩220.98 Billion | ₩- | ₩1.60 Trillion | ▼ -58.0 pp |
| 2020 | 71.8% | ₩189.48 Billion | ₩189.48 Billion | ₩- | ₩263.79 Billion | — |